Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.78
-0.94 (-3.16%)
Mar 6, 2026, 4:00 PM EST - Market closed
Roivant Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Revenue | 13.31 | 29.05 | 32.71 | 31.53 | 55.29 | 23.8 | Upgrade
|
| Revenue Growth (YoY) | -56.36% | -11.19% | 3.75% | -42.97% | 132.34% | -64.85% | Upgrade
|
| Cost of Revenue | 627.98 | 545.52 | 431.61 | 457.1 | 469.1 | 238.68 | Upgrade
|
| Gross Profit | -614.67 | -516.47 | -398.9 | -425.57 | -413.82 | -214.89 | Upgrade
|
| Selling, General & Admin | 660.59 | 570.21 | 380.53 | 383.45 | 425.03 | 259.88 | Upgrade
|
| Operating Expenses | 660.59 | 570.21 | 380.53 | 383.45 | 425.03 | 259.88 | Upgrade
|
| Operating Income | -1,275 | -1,087 | -779.43 | -809.01 | -838.85 | -474.77 | Upgrade
|
| Interest Expense | - | - | - | - | -7.04 | -2.81 | Upgrade
|
| Interest & Investment Income | 191.55 | 258.38 | 146.43 | 32.18 | 0.37 | 1.42 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -3.75 | Upgrade
|
| Other Non Operating Income (Expenses) | -44.98 | 5.04 | -60.4 | -18.87 | 73.06 | -33.41 | Upgrade
|
| EBT Excluding Unusual Items | -1,129 | -823.27 | -693.4 | -795.7 | -772.46 | -513.31 | Upgrade
|
| Gain (Loss) on Sale of Investments | 143.87 | 55.19 | -47.97 | -20.82 | 356.46 | 95.53 | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.11 | 113.5 | 5,381 | 29.28 | 5.04 | 115.36 | Upgrade
|
| Other Unusual Items | 60 | -27 | -45.5 | - | -372.9 | - | Upgrade
|
| Pretax Income | -921.73 | -681.59 | 4,568 | -884.99 | -923.75 | -898.55 | Upgrade
|
| Income Tax Expense | 84.3 | 48.17 | 21.5 | 4.08 | 0.37 | 1.69 | Upgrade
|
| Earnings From Continuing Operations | -1,006 | -729.76 | 4,546 | -889.07 | -924.12 | -900.23 | Upgrade
|
| Earnings From Discontinued Operations | - | 373.03 | -315.15 | -226.39 | - | - | Upgrade
|
| Net Income to Company | -1,006 | -356.73 | 4,231 | -1,115 | -924.12 | -900.23 | Upgrade
|
| Minority Interest in Earnings | 196.79 | 184.75 | 117.72 | 106.43 | 78.85 | 91 | Upgrade
|
| Net Income | -809.24 | -171.98 | 4,349 | -1,009 | -845.26 | -809.23 | Upgrade
|
| Net Income to Common | -809.24 | -171.98 | 4,349 | -1,009 | -845.26 | -809.23 | Upgrade
|
| Shares Outstanding (Basic) | 691 | 725 | 783 | 713 | 670 | 630 | Upgrade
|
| Shares Outstanding (Diluted) | 691 | 725 | 831 | 713 | 670 | 630 | Upgrade
|
| Shares Change (YoY) | -7.70% | -12.71% | 16.59% | 6.43% | 6.30% | 187.64% | Upgrade
|
| EPS (Basic) | -1.17 | -0.24 | 5.55 | -1.42 | -1.26 | -1.28 | Upgrade
|
| EPS (Diluted) | -1.17 | -0.24 | 5.23 | -1.42 | -1.26 | -1.28 | Upgrade
|
| Free Cash Flow | -766.86 | -844.05 | -766.65 | -856.08 | -695.17 | -557.94 | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -1.16 | -0.92 | -1.20 | -1.04 | -0.89 | Upgrade
|
| Operating Margin | -9581.19% | -3740.34% | -2382.63% | -2565.86% | -1517.29% | -1995.23% | Upgrade
|
| Profit Margin | -6079.94% | -591.96% | 13294.18% | -3200.22% | -1528.89% | -3400.86% | Upgrade
|
| Free Cash Flow Margin | -5761.49% | -2905.21% | -2343.56% | -2715.14% | -1257.40% | -2344.80% | Upgrade
|
| EBITDA | -1,264 | -1,073 | -757.39 | -790.16 | -832.92 | - | Upgrade
|
| D&A For EBITDA | 10.87 | 14.07 | 22.04 | 18.86 | 5.93 | - | Upgrade
|
| EBIT | -1,275 | -1,087 | -779.43 | -809.01 | -838.85 | -474.77 | Upgrade
|
| Effective Tax Rate | - | - | 0.47% | - | - | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 55.29 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.